| 000 | 00895 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513085644.0 | ||
| 264 | 0 | _c19960422 | |
| 008 | 199604s 0 0 eng d | ||
| 022 | _a1078-8956 | ||
| 024 | 7 |
_a10.1038/nm0496-392 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDelaney, S J | |
| 245 | 0 | 0 |
_aNew pharmaceutical approaches to the treatment of cystic fibrosis. _h[electronic resource] |
| 260 |
_bNature medicine _cApr 1996 |
||
| 300 |
_a392-3 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Journal Article; Review | ||
| 650 | 0 | 4 |
_aCystic Fibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aCystic Fibrosis Transmembrane Conductance Regulator _xgenetics |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aWainwright, B J | |
| 773 | 0 |
_tNature medicine _gvol. 2 _gno. 4 _gp. 392-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nm0496-392 _zAvailable from publisher's website |
| 999 |
_c8596990 _d8596990 |
||